13F reference period
Q2 2026
Security Snapshot
Enveric Biosciences, Inc. - Common Stock, par value, $0.01 per share (ENVB) Institutional Ownership
CUSIP: 29405E505
13F Institutional Holders and Ownership History from Q4 2025 to Q3 2026
Institutions Reporting
23
Shares (Excl. Options)
526.89K
Full value: 526,891 · shares · 30 Jun 2026Price
$1.38
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value, $0.01 per share
- Symbol
- ENVB on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 526,891
- Total 13F value
- $732,636
- Portfolio coverage rank
- 0%
- Share change
- +471,915
- Value change
- +$656,746
- Number of holders
- 23
- Shares outstanding
- 4,477,612
- SEC-reported price per share
- $1.43
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- ENVB - Enveric Biosciences, Inc. - Common Stock, par value, $0.01 per share is tracked under CUSIP 29405E505.
- 23 institutions reported positions in Q2 2026.
- 5 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 11 to 23 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$106.59K
Full value: $106,594 · USD · 31 Mar 2026.$732.64K
Full value: $732,636 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 23 institutions filings for Q2 2026.
Security key
29405E505
13F reference period
Q2 2026
13F holders
23
13D/G owners
5
CIK / CUSIP context first
Open Q2 2026 holders
ENVB full holder history
Enveric Biosciences, Inc. SEC filings
Enveric Biosciences, Inc. company facts
Enveric Biosciences, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29405E505:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
5
Security
ENVB
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 10% | $550,925 | 405,092 | Armistice Capital, LLC | 30 Jun 2026 | |||
| Sio Capital Management, LLC | 7.4% | $471,900 | 330,000 | Sio Capital Management, LLC | 30 Sep 2026 | |||
| Ayrton Capital LLC | 2.9% | -71% | $151,157 | -$744,355 | 111,145 | -83% | Ayrton Capital LLC | 30 Jun 2026 |
| INTRACOASTAL CAPITAL, LLC | 5% | 0% | $278,572 | +$155,982 | 71,246 | +127% | Mitchell P. Kopin | 27 Jan 2026 |
| Lind Global Fund III LP | 1.4% | -81% | $70,538 | -$148,738 | 51,866 | -68% | EASTON JEFF | 30 Jun 2026 |
As of 30 Jun 2026,
23
institutional investors reported holding
shares of
Enveric Biosciences, Inc. - Common Stock, par value, $0.01 per share (ENVB).
This represents
12%
of the company’s total
outstanding shares.
526.89K
Full value: 526,891 · shares · 30 Jun 20264.48M
Full value: 4,477,612 · shares · Stored outstanding share count13F concentration
Top 24 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
12%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Sio Capital Management, LLC | 4% | 180,000 | 0.04% | $248,400 | |
| Ikarian Capital, LLC | 2.2% | 100,002 | 0.02% | $138,003 | |
| AdvisorShares Investments LLC | 0.79% | 35,417 | +109% | 0.01% | $48,875 |
| RENAISSANCE TECHNOLOGIES LLC | 0.72% | 32,058 | 0% | $44,240 | |
| ARMISTICE CAPITAL, LLC | 0.71% | 32,000 | 0% | $44,160 | |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.67% | 30,142 | 0% | $41,596 | |
| XTX Topco Ltd | 0.42% | 18,990 | 0% | $26,206 | |
| HRT FINANCIAL LP | 0.35% | 15,458 | 0% | $21,000 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.33% | 14,912 | 0% | $20,579 | |
| CITADEL ADVISORS LLC | 0.31% | 13,965 | 0% | $19,272 | |
| StoneX Group Inc. | 0.26% | 11,814 | 0% | $21,882 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.26% | 11,794 | -63% | 0% | $16,274 |
| MORGAN STANLEY | 0.24% | 10,733 | 0% | $14,812 | |
| Virtu Financial LLC | 0.24% | 10,690 | 0% | $15,000 | |
| Tower Research Capital LLC (TRC) | 0.11% | 4,984 | +352% | 0% | $6,878 |
| SBI Securities Co., Ltd. | 0.06% | 2,676 | +3124% | 0% | $3,693 |
| JONES FINANCIAL COMPANIES LLLP | 0.02% | 1,000 | 0% | 0% | $1,415 |
| UBS Group AG | 0% | 201 | -94% | 0% | $277 |
| BlackRock, Inc. | 0% | 51 | 0% | 0% | $70 |
| NATIONAL BANK OF CANADA /FI/ | 0% | 1 | 0% | 0% | $1 |
| DANSKE BANK A/S | 0% | 1 | 0% | 0% | $1 |
| OSAIC HOLDINGS, INC. | 0% | 1 | 0% | $1 | |
| WELLS FARGO & COMPANY/MN | 0% | 1 | 0% | 0% | $1 |
| GROUP ONE TRADING LLC | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Headline period
Q2 2026
Rows shown
1-4 of 4